This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Bifascicular Block or Syncope
and you are
over 18
years old
The phase for this study is not defined.
Show me locations

The purpose

Study Objective The purpose of this study is to evaluate the efficacy of bradycardia pacing with respect to patient symptoms in patients with bifascicular block and syncope of unexplained origin.

Provided treatments

  • Device: DDD60 (INSIGNIA® pacing systems Guidant (Boston Scientific)
  • Device: DDD60 (INSIGNIA® pacing systems Guidant (Boston Scientific)

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01463358. The sponsor of the trial is Boston Scientific Corporation and it is looking for 101 volunteers for the current phase.
Official trial title:
Prevention of Syncope by Cardiac Pacing in Patients With Bifascicular Block